Literature DB >> 31004199

Function of the cargo sorting dileucine motif in a cytomegalovirus immune evasion protein.

Annette Fink1,2, Snježana Mikuličić1, Franziska Blaum1, Matthias J Reddehase3, Luise Florin4, Niels A W Lemmermann5.   

Abstract

As an immune evasion mechanism, cytomegaloviruses (CMVs) have evolved proteins that interfere with cell surface trafficking of MHC class-I (MHC-I) molecules to tone down recognition by antiviral CD8 T cells. This interference can affect the trafficking of recently peptide-loaded MHC-I from the endoplasmic reticulum to the cell surface, thus modulating the presentation of viral peptides, as well as the recycling of pre-existing cell surface MHC-I, resulting in reduction of the level of overall MHC-I cell surface expression. Murine cytomegalovirus (mCMV) was paradigmatic in that it led to the discovery of this immune evasion strategy of CMVs. Members of its m02-m16 gene family code for type-I transmembrane glycoproteins, proven or predicted, most of which carry cargo sorting motifs in their cytoplasmic, C-terminal tail. For the m06 gene product m06 (gp48), the cargo has been identified as being MHC-I, which is linked by m06 to cellular adapter proteins AP-1A and AP-3A through the dileucine motif EPLARLL. Both APs are involved in trans-Golgi network (TGN) cargo sorting and, based on transfection studies, their engagement by the dileucine motif was proposed to be absolutely required to prevent MHC-I exposure at the cell surface. Here, we have tested this prediction in an infection system with the herein newly described recombinant virus mCMV-m06AA, in which the dileucine motif is destroyed by replacing EPLARLL with EPLARAA. This mutation has a phenotype in that the transition of m06-MHC-I complexes from early endosomes (EE) to late endosomes (LE)/lysosomes for degradation is blocked. Consistent with the binding of the MHC-I α-chain to the luminal domain of m06, the m06-mediated disposal of MHC-I did not require the β2m chain of mature MHC-I. Unexpectedly, however, disconnecting MHC-I cargo from AP-1A/3A by the motif mutation in m06 had no notable rescuing impact on overall cell surface MHC-I, though it resulted in some improvement of the presentation of viral antigenic peptides by recently peptide-loaded MHC-I. Thus, the current view on the mechanism by which m06 mediates immune evasion needs to be revised. While the cargo sorting motif is critically involved in the disposal of m06-bound MHC-I in the endosomal/lysosomal pathway at the stage of EE to LE transition, this motif-mediated disposal is not the critical step by which m06 causes immune evasion. We rather propose that engagement of AP-1A/3A by the cargo sorting motif in m06 routes the m06-MHC-I complexes into the endosomal pathway and thereby detracts them from the constitutive cell surface transport.

Entities:  

Keywords:  Adapter proteins (AP-1, AP-3); Antigen presentation; Cargo sorting; Cytomegalovirus; Dileucine motif; Early endosomes (EE); Endosomal pathway; Endosomal recycling compartment (ERC); Immune evasion; Late endosomes (LE); MHC class-I; MHC class-I trafficking; Trans-Golgi network (TGN); m06 protein

Mesh:

Substances:

Year:  2019        PMID: 31004199     DOI: 10.1007/s00430-019-00604-x

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  46 in total

1.  The glycoprotein gp48 of murine cytomegalovirusL proteasome-dependent cytosolic dislocation and degradation.

Authors:  Anja Bubeck; Uwe Reusch; Markus Wagner; Thomas Ruppert; Walter Muranyi; Peter M Kloetzel; Ulrich H Koszinowski
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 2.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance.

Authors:  Matthias J Reddehase
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 3.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

4.  The immune evasion paradox: immunoevasins of murine cytomegalovirus enhance priming of CD8 T cells by preventing negative feedback regulation.

Authors:  Verena Böhm; Christian O Simon; Jürgen Podlech; Christof K Seckert; Dorothea Gendig; Petra Deegen; Dorothea Gillert-Marien; Niels A W Lemmermann; Rafaela Holtappels; Matthias J Reddehase
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules.

Authors:  Xiuju Lu; Daniel G Kavanagh; Ann B Hill
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs.

Authors:  S Kurz; H P Steffens; A Mayer; J R Harris; M J Reddehase
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Analysis of the complete DNA sequence of murine cytomegalovirus.

Authors:  W D Rawlinson; H E Farrell; B G Barrell
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

Review 8.  Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions.

Authors:  Niels A W Lemmermann; Annette Fink; Jürgen Podlech; Stefan Ebert; Vanessa Wilhelmi; Verena Böhm; Rafaela Holtappels; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2012-09-09       Impact factor: 3.402

9.  Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response.

Authors:  Agnieszka Kielczewska; Michal Pyzik; Tianhe Sun; Astrid Krmpotic; Melissa B Lodoen; Michael W Munks; Marina Babic; Ann B Hill; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier; Silvia M Vidal
Journal:  J Exp Med       Date:  2009-03-02       Impact factor: 14.307

10.  Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus.

Authors:  Markus Wagner; Anja Gutermann; Jürgen Podlech; Matthias J Reddehase; Ulrich H Koszinowski
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  5 in total

1.  Stochastic Episodes of Latent Cytomegalovirus Transcription Drive CD8 T-Cell "Memory Inflation" and Avoid Immune Evasion.

Authors:  Marion Griessl; Angelique Renzaho; Kirsten Freitag; Christof K Seckert; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

2.  Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation.

Authors:  Rafaela Holtappels; Sina I Schader; Oliver Oettel; Jürgen Podlech; Christof K Seckert; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-04-15       Impact factor: 5.293

3.  Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.

Authors:  Emin Gezinir; Jürgen Podlech; Kerstin M Gergely; Sara Becker; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-06-09       Impact factor: 5.293

4.  Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells.

Authors:  Sara Becker; Annette Fink; Jürgen Podlech; Irina Giese; Julia K Schmiedeke; Thomas Bukur; Matthias J Reddehase; Niels A Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-08-26       Impact factor: 5.293

Review 5.  Host-Adapted Gene Families Involved in Murine Cytomegalovirus Immune Evasion.

Authors:  Sara Becker; Annette Fink; Jürgen Podlech; Matthias J Reddehase; Niels A Lemmermann
Journal:  Viruses       Date:  2022-01-11       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.